MATERNITY AND PATERNITY LEAVE: A GUIDED APPROACH FOR EMPLOYERS WITH EMPLOYEES UTILIZING SURROGATE BIRTHS AND OTHER REPRODUCTIVE METHODS.
- Published in:
- Cornell HR Review, 2012, p. 1
- By:
- Publication type:
- Article
Works matching DE "CUBIST Pharmaceuticals Inc."
Results: 12
1
2
15 February News.
- Published in:
- Clinical Infectious Diseases, 2014, v. 58, n. 4, p. i, doi. 10.1093/cid/cit817
- Publication type:
- Article
3
Daptomycin: From the Mountain to the Clinic, with Essential Help from Francis Tally, MD.
- Published in:
- Clinical Infectious Diseases, 2010, v. 50, p. S10, doi. 10.1086/647938
- By:
- Publication type:
- Article
4
Cubicin Meets Primary End Points in Staphylococcus aureus Endocarditis/ Bacteremia Study.
- Published in:
- Clinical Infectious Diseases, 2005, v. 41, n. 4, p. 1
- Publication type:
- Article
5
News.
- Published in:
- Clinical Infectious Diseases, 2003, v. 37, n. 10, p. i, doi. 10.1086/520260
- By:
- Publication type:
- Article
6
THINKING INSIDE-THE-BOX, KRILL V. CUBIST PHARMACEUTICALS: DOES FMLA NEED TO BE AMENDED TO ADDRESS GESTATIONAL SURROGACY AND HOW SHOULD COMPANIES ADDRESS PAID "MATERNITY" LEAVE?
- Published in:
- Journal of Law & Family Studies, 2012, v. 14, n. 1, p. 137
- By:
- Publication type:
- Article
7
CB-182,804 enters Phase I clinical trial for Gram-negative infections.
- Published in:
- Expert Review of Anti-infective Therapy, 2009, v. 7, n. 3, p. 255
- Publication type:
- Article
8
Fresh from the pipeline: Daptomycin.
- Published in:
- Nature Reviews Drug Discovery, 2003, v. 2, n. 12, p. 943, doi. 10.1038/nrd1258
- By:
- Publication type:
- Article
9
Erratum.
- Published in:
- 2016
- Publication type:
- Correction Notice
10
Merck splashes on Cubist, antibiotics prospects brighten.
- Published in:
- Nature Biotechnology, 2015, v. 33, n. 2, p. 120, doi. 10.1038/nbt0215-120
- By:
- Publication type:
- Article
11
Profile: Julian Davies.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 7, p. 727, doi. 10.1038/nbt0708-727
- By:
- Publication type:
- Article
12
Cubist highlights FDA's antibiotic resistance.
- Published in:
- Nature Biotechnology, 2002, v. 20, n. 3, p. 206, doi. 10.1038/nbt0302-206
- By:
- Publication type:
- Article